ISSN: 2332-0702

Journal d'hygiène bucco-dentaire et de santé

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

In The Era of Modern Dental Care Anti-Thrombotic Medications

Erica James

Due to the development of novel anti-thrombotic medicines and modifications to the approved indications for their use, anti-thrombotic treatment has undergone significant changes in recent years. Dentists are consequently seeing more patients who are receiving anti-thrombotic therapy and who have a higher risk of bleeding. The current research seeks to evaluate the literature on current anti-thrombotic therapies and provide details on their dental implications. The material published between 2000 and 2016 was searched online. Both articles discussing evidence-based clinical recommendations for anti-thrombotic therapies and publications documenting the use of anti-thrombotic drugs were incorporated. The publications were reviewed based on the treatment protocol criteria and their applicability to dentistry. A total of 5,539 papers were found: 132 of these articles mention direct anti-thrombotic drugs, while 56 of the 554 evidence-based clinical guidelines found dealt with anti-thrombotic therapy procedures. During dental procedures, bleeding is a possibility. Dentists need to be knowledgeable about the effects of new generation anti-thrombotic medications on dental treatment as well as practical ways to achieve haemostasis because more patients are taking them [1-5].